29 May 2023
Acquired brain injuries – A special interest group
Recent studies indicate that acquired brain injuries, such as traumatic brain injury, trigger potentially harmful responses that may lead to neurodegenerative pathology. “Acquired ...
17 May 2023
Superstars coming to Lund for pharmaceutical symposium sponsored by MultiPark
Several Nobel laureates, renowned scientists, and successful biotech entrepreneurs are coming to Lund in May to participate in the Lund Spring Symposium, an international pharmaceu...
13 Apr 2023
Double success for MultiPark research groups in prestigious EU grant round
Three researchers at Lund University, all with a long list of significant research credentials, have been awarded the ERC Advanced Grant worth EUR 2.5 million each to further devel...
11 Apr 2023
WORLD PARKINSON's DAY: Transplantations for Parkinson's disease – A time travel
In the early 1950s, no one knew what caused Parkinson's disease. Then, Arvid Carlsson's discovery of dopamine opened the door to world-leading transplantations for Parkinson's pati...
28 Mar 2023
Genetics of Neurodegenerative Diseases – A special interest group
Genetics are one of the keys to understanding neurodegenerative disease. That is why MultiPark researchers with expertise in genetics gather across research groups. Genetics of neu...
20 Mar 2023
Genes and environment in PD – PhD interview with Kajsa Brolin
Kajsa Brolin explores how our genes and environment affect the risk of developing Parkinson’s disease. March 27, she defends her Ph.D. project partly based on MultiPark’s biobank s...
16 Mar 2023
Meet Our Scientists! – New podcast by young MultiPark researchers
Looking for the next step in your career? In need of some scientific inspiration? Or are you just curious about what MultiPark´s senior researchers are doing and their professional...
13 Mar 2023
STEM-PD : A bench-to-bedside story by MultiPark researchers
After a decade of protocol development and preparations, MultiPark researchers have finally launched the clinical trial. Recently, dopamine-producing cells generated from embryonic...
8 Mar 2023
Electrodes grown in the brain
The boundaries between biology and technology are becoming blurred. Researchers at Linköping, Lund, and Gothenburg universities in Sweden have successfully grown electrodes in livi...
28 Feb 2023
First patient receives milestone stem cell-based transplant for Parkinson’s Disease
On 13th of February, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. The product has been develope...
10 Feb 2023
Does Alzheimer’s disease start inside neurons? – PhD interview with Tomas Roos
The aggregation of the protein Amyloid-beta (Abeta) into plaques outside the nerve cells has been recognized in patients with Alzheimer’s disease since 1905. But eliminating the pl...
3 Feb 2023
Huntington’s metabolic dysfunctions – PhD interview with Elna Dickson
Huntington's disease is known as the "dance disease" due to the patient's characteristic motor symptoms. However, Elna Dickson's Ph.D. project shows that the disease also leads to ...
13 Jan 2023
Cognitive disease beyond the brain – PhD interview with Keivan Javanshiri
Keivan Javanshiri’s Ph.D. project explores cardiac and vascular pathologies in Lewy body dementia and Alzheimer's disease. January 20, he defends his thesis. Here, he shares the mo...
12 Jan 2023
Nerve cells could transform the treatment of Parkinson’s
At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disea...
10 Jan 2023
Why dopamine receptor type matters – PhD interview with Katrine Skovgård
Katrine Skovgård’s Ph.D. project sheds light on the dysfunctions in the brain through which dopaminergic pharmacotherapies for Parkinson’s disease affect motor behaviors. January 1...
3 Jan 2023
Optimal blood tests for development of new therapies of Alzheimer’s disease
A new study have identified which blood tests are best at detecting Alzheimer’s disease during the earliest stages, and also another blood test that is optimal for detecting releva...
21 Dec 2022
MultiPark – Closing the circle of 2022 and looking forward to 2023
We ended the MultiPark year in December as we started it in January: with a MultiPark Retreat! The December retreat was our first big meeting IRL after the pandemic, and it turned ...
14 Dec 2022
Molecular signaling in neurodegenerative disorders – A special interest group
MultiPark’s new special interest groups (SIGs) address essential scientific and technological needs and provide opportunities for professional development and network formation to ...
8 Dec 2022
Nobel Prize winner Arvid Carlsson – 7 things you perhaps did not know about him and his research
2 Dec 2022
Walking with neurodegeneration – PhD interview with Magnus Lindh-Rengifo
Walking is probably more cognitively demanding than you think. Magnus Lindh-Rengifo defends his thesis about walking aspects in neurodegenerative disorders on December 16. Read abo...